Revance Therapeutics, Inc. acquired target

Revance Therapeutics, Inc. -> target · $3.65

About Crown Crown, a privately held, fully integrated global skincare company, is committed to developing and providing a diverse portfolio of aesthetic, premium and therapeutic skincare products that improve the quality of life for its consumers throughout th